DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix
NCT00004866 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2012-05-16
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of DX-8951f in treating women who have advanced or recurrent cancer of the cervix.
Conditions
Interventions
- DRUG
-
exatecan mesylate
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Robert L. DeJager, MD, FACP · Daiichi Sankyo
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-01-31
- Primary Completion
- 2003-09-30
- Completion
- 2003-09-30
Countries
- United States
Study Locations
More Related Trials
-
Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
NCT00039442 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel in Treating Patients With Advanced Cancer of the Cervix
NCT00003445 ·Status: COMPLETED ·Phase: PHASE2
-
Gene Therapy in Treating Patients With Advanced Head and Neck Cancer
NCT00009841 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer
NCT05998941 ·Status: WITHDRAWN ·Phase: PHASE2
-
Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix
NCT00006224 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer
NCT02291055 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
NCT01266460 ·Status: COMPLETED ·Phase: PHASE2
-
Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
NCT00016926 ·Status: COMPLETED ·Phase: PHASE2
-
Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer
NCT06997094 ·Status: RECRUITING ·Phase: PHASE1
-
Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix
NCT00087113 ·Status: COMPLETED ·Phase: PHASE2
-
Ixabepilone to Treat Cervical Cancer
NCT00924066 ·Status: TERMINATED ·Phase: PHASE2
-
Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix
NCT00005965 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Ivonescimab in People With Endometrial and Cervical Cancers
NCT06925724 ·Status: RECRUITING ·Phase: PHASE2
-
Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00062387 ·Status: TERMINATED ·Phase: PHASE2
-
Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
NCT00003443 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
NCT04982237 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
NCT02164461 ·Status: COMPLETED ·Phase: PHASE1
-
Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
NCT00006482 ·Status: TERMINATED ·Phase: PHASE2
-
Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
NCT00087126 ·Status: COMPLETED ·Phase: PHASE2
-
Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix
NCT00178269 ·Status: COMPLETED ·Phase: PHASE2
-
Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer
NCT00257348 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
NCT00002562 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck
NCT01285635 ·Status: TERMINATED ·Phase: PHASE2
-
S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
NCT00003908 ·Status: COMPLETED ·Phase: PHASE2
-
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
NCT00278434 ·Status: TERMINATED ·Phase: PHASE1